Đang chuẩn bị liên kết để tải về tài liệu:
Mutation status coupled with RNAsequencing data can efficiently identify important non-significantly mutated genes serving as diagnostic biomarkers of endometrial cancer

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Endometrial cancers (ECs) are one of the most common types of malignant tumor in females. Substantial efforts had been made to identify significantly mutated genes (SMGs) in ECs and use them as biomarkers for the classification of histological subtypes and the prediction of clinical outcomes. |

TÀI LIỆU LIÊN QUAN

Evaluating the prognostic value of ERCC1 and thymidylate synthase expression and the epidermal growth factor receptor mutation status in adenocarcinoma non-small-cell lung cancer

The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients

EGFR mutation status in Tunisian nonsmall-cell lung cancer patients evaluated by mutation-specific immunohistochemistry

Epidermal growth factor receptor gene mutation status in pure squamous-cell lung cancer in Chinese patients

Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma

Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers

Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery

Clinicopathological features and EGFR gene mutation status in elderly patients with resected non–small-cell lung cancer

Vasculogenic mimicry, a negative indicator for progression free survival of lung adenocarcinoma irrespective of first line treatment and epithelial growth factor receptor mutation status

Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status